Results 211 to 220 of about 64,337 (253)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 2002
Testicular cancer remains a major success story in the realm of solid tumors. Although testicular cancer is highly treatable and curable, there are still many young men who succumb to the disease. Over the past year, important data regarding the diagnosis, treatment, and prognosis of testicular cancer have been reported. The significance of genetic and
Beth A, Hellerstedt, Kenneth J, Pienta
openaire +2 more sources
Testicular cancer remains a major success story in the realm of solid tumors. Although testicular cancer is highly treatable and curable, there are still many young men who succumb to the disease. Over the past year, important data regarding the diagnosis, treatment, and prognosis of testicular cancer have been reported. The significance of genetic and
Beth A, Hellerstedt, Kenneth J, Pienta
openaire +2 more sources
Current Problems in Cancer, 1998
The following article provides a comprehensive review of male germ cell tumors; the pathology and the clinical manifestations of the tumors are discussed, as are the modern concepts of clinical staging. Patients with bulky stage II and stage III non-seminomatous germ cell tumors are treated with chemotherapy. The new international classification system
openaire +2 more sources
The following article provides a comprehensive review of male germ cell tumors; the pathology and the clinical manifestations of the tumors are discussed, as are the modern concepts of clinical staging. Patients with bulky stage II and stage III non-seminomatous germ cell tumors are treated with chemotherapy. The new international classification system
openaire +2 more sources
Guidelines on Testicular Cancer
European Urology, 2005To up-date the 2001 version of the EAU testicular cancer guidelines.A non-structured literature review until January 2005 using the MEDLINE database has been performed. Literature has been classified according to evidence-based medicine levels.Testicular cancer is a highly curable disease.
Albers, Peter +8 more
openaire +2 more sources
The Lancet
Testicular cancer is the most common solid malignancy in people with testicles aged 15-44 years, accounting for 1-2% of all tumours in males of all ages. Approximately 95% of testicular cancers are testicular germ cell tumours. This Seminar focuses on testicular cancer, with an emphasis on testicular germ cell tumours.
Julian, Chavarriaga +4 more
openaire +2 more sources
Testicular cancer is the most common solid malignancy in people with testicles aged 15-44 years, accounting for 1-2% of all tumours in males of all ages. Approximately 95% of testicular cancers are testicular germ cell tumours. This Seminar focuses on testicular cancer, with an emphasis on testicular germ cell tumours.
Julian, Chavarriaga +4 more
openaire +2 more sources
Testicular Cancer and Cryptorchidism
British Journal of Urology, 1992Summary The records of 273 patients with germ cell tumours of the testis referred between 1970 and July 1991 were reviewed. There were 25 (9%) black, 40 (14%) mixed race and 214 (77%) white patients. Histology showed seminoma in 53% and non‐seminomatous and germ cell tumours in 47% of patients. Maldescent of the
R P, Abratt, V B, Reddi, L A, Sarembock
openaire +2 more sources
Infertility with Testicular Cancer
Urologic Clinics of North America, 2015Testicular germ cell cancer is one of the most curable cancers. Most patients are treated during their reproductive years, making infertility a significant quality of life issue after successful treatment. This focused review evaluates the factors that contribute to infertility and specific fertility risks with the various testicular cancer treatments.
Kevin A, Ostrowski, Thomas J, Walsh
openaire +2 more sources
Acta Oncologica, 1988
Testicular cancer, which predominantly occurs in young men, has become increasingly common; it is presently the most common malignancy in men aged 20-34. Despite a lack of knowledge of aetiology, empirical advances, particularly in the management of patients with advanced disease, have been dramatic.
openaire +2 more sources
Testicular cancer, which predominantly occurs in young men, has become increasingly common; it is presently the most common malignancy in men aged 20-34. Despite a lack of knowledge of aetiology, empirical advances, particularly in the management of patients with advanced disease, have been dramatic.
openaire +2 more sources
Cryptorchidism and Testicular Cancer
Journal of Urology, 1980An analysis of 125 patients with a history or clinical evidence of cryptorchidism and testicular germinal tumor treated at our hospital from 1934 to 1975 is presented. Cryptorchidism was corrected ipsilaterally or contralaterally in 83 patients with intrascrotal testis cancer when they were from 4 to 42 years old, either spontaneously (21 patients), by
M A, Batata +6 more
openaire +2 more sources
Testicular cancer in cryptorchids
Cancer, 1982One-hundred thirty-seven patients with a history or clinical evidence of cryptorchidism and testicular germinal tumor were treated at our hospital from 1934 to 1976. Cryptorchidism was corrected ipsilaterally or contralaterally in 93 patients with intrascrotal testis cancer when they were from 2 to 42 years old, either spontaneously (24 patients), by ...
M A, Batata +4 more
openaire +2 more sources
Screening for testicular cancer
Cochrane Database of Systematic Reviews, 2011Testicular cancer commonly affects men aged between 20 and 35 years. Screening for testicular cancer may reduce both morbidity and mortality, yet the effectiveness of any method is unknown. Equally, screening may also promote treatment procedures that are unwarranted or may adversely affect the health outcomes of the patient with no net benefit ...
Dragan, Ilic, Marie L, Misso
openaire +2 more sources